Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Bile Duct Cancer|Gall Bladder Cancer|Breast Cancer|Neuroendocrine Tumors|Ovarian Cancer|Pancreatic Adenocarcinoma|Soft Tissue Sarcoma|Vulvar Cancer|Prostate Cancer
Interventions: DRUG: Atezolizumab|DRUG: Tivozanib
Sponsor: University of Florida
Collaborators: Genentech, Inc.|Aveo Oncology Pharmaceuticals